VAM
GILD icon

Visium Asset Management’s Gilead Sciences GILD Stock Holding History

Visium Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,120,600
Closed -$263M – 797
2013
Q2 		$263M Buy
+5,120,600
New +$267M 6.14% 1

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Visium Asset Management's GILD Position: Q2 2016 in Review

Visium Asset Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 752,693 shares — an estimated $69.1M sold.

Visium Asset Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $116M in Q2 2013. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Visium Asset Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 752,693 Gilead Sciences shares in Q2 2016, an estimated $69.1M.
  • Visium Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Visium Asset Management's Gilead Sciences position peaked at $116M in Q2 2013.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.